Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid
Study Details
Study Description
Brief Summary
As many as 70-85% subjects diagnosed with a follicular lesion on biopsy and undergoing surgery will have benign lesions verified by histopathology after surgery.
Currently there is no method of pre-operatively diagnosing benign follicular lesions, as a result these subjects will have had surgery for diagnosis of a benign lesion.
The aim of this study is to see whether shear-wave elastography, a new ultrasound technology can help pre-operatively diagnose benign follicular lesions. If successful, a lot of patients will not need surgery for the diagnosis of a benign lesion.
The main goal of this study will be to evaluate the diagnostic accuracy of a new ultrasound technology, shear-wave elastography (SWE), for the diagnosis of malignancy in follicular lesions. Participants who have been diagnosed with a follicular lesion on thyroid biopsy and are scheduled for thyroid surgery will be eligible to participate. All participants will undergo a detailed ultrasound examination prior to their surgery. The results of the ultrasound will be compared with histopathology after surgery to test the diagnostic accuracy of SWE.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Shear-Wave Elastography Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision. |
Device: Shear-Wave Elastography
Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Shear-Wave Elastography (SWE) Values in kiloPascals (kPa) [Baseline (Day 0)]
Elastography provides a quantitative score of thyroid nodule stiffness that is expected to correlate with the biological nature of the nodule. Mean SWE values, in three planes: traverse plane, sagittal plane and transverse plane with nodule in the center, of all benign lesions were compared with mean SWE values of all malignant lesions on histopathology obtained post surgery.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients diagnosed with a Follicular Neoplasm on fine needle aspiration biopsy
-
Patients >18 years of age
Exclusion Criteria
- None
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Massachusetts General Hospital | Boston | Massachusetts | United States | 02114 |
Sponsors and Collaborators
- Massachusetts General Hospital
Investigators
- Principal Investigator: Antonia E. Stephen, MD, Massachusetts General Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2007P001161
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Shear-Wave Elastography |
---|---|
Arm/Group Description | Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision. |
Period Title: Overall Study | |
STARTED | 35 |
COMPLETED | 35 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Shear-Wave Elastography |
---|---|
Arm/Group Description | Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision. |
Overall Participants | 35 |
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
55
(16.1)
|
Sex: Female, Male (Count of Participants) | |
Female |
23
65.7%
|
Male |
12
34.3%
|
Region of Enrollment (participants) [Number] | |
United States |
35
100%
|
Outcome Measures
Title | Shear-Wave Elastography (SWE) Values in kiloPascals (kPa) |
---|---|
Description | Elastography provides a quantitative score of thyroid nodule stiffness that is expected to correlate with the biological nature of the nodule. Mean SWE values, in three planes: traverse plane, sagittal plane and transverse plane with nodule in the center, of all benign lesions were compared with mean SWE values of all malignant lesions on histopathology obtained post surgery. |
Time Frame | Baseline (Day 0) |
Outcome Measure Data
Analysis Population Description |
---|
All enrolled participants. |
Arm/Group Title | Shear-Wave Elastography, Benign Lesions | Shear-Wave Elastography, Malignant Lesions |
---|---|---|
Arm/Group Description | Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision. This cohort includes all participants with benign lesions. | Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision. This cohort Includes all participants with malignant lesions. |
Measure Participants | 24 | 11 |
Transverse Plane |
17.50
(7.65)
|
31.03
(13.54)
|
Sagittal Plane |
23.64
(14.86)
|
32.14
(11.98)
|
Transverse Plane with Nodule in the Center |
17.89
(9.1)
|
33.80
(12.50)
|
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Shear-Wave Elastography | |
Arm/Group Description | Shear-Wave Elastography was performed on patients scheduled for partial/total thyroidectomy. Results were compared with pathology from surgical excision. | |
All Cause Mortality |
||
Shear-Wave Elastography | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Shear-Wave Elastography | ||
Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Shear-Wave Elastography | ||
Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Antonia Stephen, MD |
---|---|
Organization | Massachusetts General Hospital |
Phone | |
ASTEPHEN@PARTNERS.ORG |
- 2007P001161